Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

1. Rodrigues, J.S.
2. Chenlo, M.
3. Bravo, S.B.
4. Perez-Romero, S.
5. Suarez-Fariña, M.
6. Sobrino, T.
7. Sanz-Pamplona, R.
8. González-Prieto, R.
9. Blanco Freire, M.N.
10. Nogueiras, R.
11. López, M.
12. Fugazzola, L.
13. Cameselle-Teijeiro, J.M.
14. Alvarez, C.V.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/S41467-024-51057-7 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus